Table 2.
Clinical and functional characteristics at baseline and after 6 months of CRT
| Parameter | I group (n = 20) | II group (n = 39) | P | |
|---|---|---|---|---|
| NYHA functional class | At baseline | 2.6±0.6 | 2.8±0.6 | 0.107 |
| After 6 months | 1.9±0.7a | 2.2±0.9a | 0.169 | |
| 6-min walking distance, (m) | At baseline | 329.2±86.0 | 320.9±98.7 | 0.651 |
| After 6 months | 421.5±66.7a | 381.5±112.2a | 0.169 | |
| LVEF by 3D echocardiography, (%) | At baseline | 30.0±2.7 | 29.6±3.9 | 0.458 |
| After 6 months | 40.1±5.4a | 34.4±3.8a | < 0.001 | |
| Mean changes | 10[6.2;13.2] | 5[3;7] | < 0.001 | |
| LVEDV by 3D echocardiography, (ml) | At baseline | 233.4±65.0 | 231.2±65.9 | 0.820 |
| After 6 months | 159.1±39.4a | 213.2±63.7a | < 0.001 | |
| Mean changes | −73.0[− 101.0;-51.7] | −15.0[− 31.0;-8.0] | < 0.001 | |
| LVESV by 3D echocardiography, (ml) | At baseline | 163.4±46.5 | 163.5±51.3 | 0.957 |
| After 6 months | 95.8±27.1a | 140.0±46.7a | < 0.001 | |
| Mean changes | −61.0[−91.0;-47.7] | − 20.0[− 38.0;-12.0] | < 0.001 | |
| QRS, (ms) | At baseline | 139.1±44.2 | 141.8±36.7 | 0.996 |
| After 6 months | 153.6±26.2 | 160.2±26.0a | 0.367 | |
a – difference between baseline and postimplant value (р < 0.05)